Lucerno Dynamics
Cary
About Lucerno Dynamics
Lucerno Dynamics' breakthrough system can dynamically detect, quantify, and record with high-fidelity the presence of radiolabeled biomarkers in tissue quickly, safely, and inexpensively. This technology has potential human applications in assuring the quality of PET injections, measuring arterial input function non-invasively, assessing inflammation, monitoring therapy response of superficial tumors, and several others. Related technology has been developed for use in animal research for preclinical evaluation of compounds. It was founded in 2011 and headquartered in Cary, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Sep 2023)
- Website: lucerno.com
- Phone: (919) 371-6800
Industries & Categories
Biotechnology, Health Care, Information Services, Marketing, Medical
Social Profiles
Canonical: https://fsome.com/organization/lucerno-dynamics-77538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.